The Serum Analysis of Dampness Syndrome in Patients with Coronary Heart Disease and Chronic Renal Failure Based on the Theory of “Same Syndromes in Different Diseases”

<table class="table-group" id="tab7"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Metabolite</td><td class="align_center">Pathway</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Tyramine</td><td class="align_center">Tyramine metabolism</td></tr><tr><td class="align_left">Arachidonic acid</td><td class="align_center">Arachidonic acid metabolism</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Metabolic pathways involved in parts of differential metabolites from serums of patients with CHD and CRF showing dampness syndrome.

BioMed Research International

tab7

Table 7

Table 7: The Serum Analysis of Dampness Syndrome in Patients with Coronary Heart Disease and Chronic Renal Failure Based on the Theory of “Same Syndromes in Different Diseases” 

Table 7 | The Serum Analysis of Dampness Syndrome in Patients with Coronary Heart Disease and Chronic Renal Failure Based on the Theory of “Same Syndromes in Different Diseases” 